ICN-2001-1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameICN-2001-1
Drug Alias Nameanticancer therapeutics (Valeant)anticancer therapeutics (ICN)ICN-2001-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBausch Health Companies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBausch Health Companies Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A